Canichella, M.; Cerretti, R.; Trawinska, M.M.; Cefalo, M.; Cupelli, L.; Mazzone, C.; Checcoli, A.; Di Rocco, A.; de Fabritiis, P.; Abruzzese, E.
Fatal Early Toxicity After Allogeneic Stem Cell Transplantation in Heavily Pretreated Follicular Lymphoma: Clinical Decision-Making Between Bispecific Antibodies and CAR T-Cell Therapy. Targets 2025, 3, 37.
https://doi.org/10.3390/targets3040037
AMA Style
Canichella M, Cerretti R, Trawinska MM, Cefalo M, Cupelli L, Mazzone C, Checcoli A, Di Rocco A, de Fabritiis P, Abruzzese E.
Fatal Early Toxicity After Allogeneic Stem Cell Transplantation in Heavily Pretreated Follicular Lymphoma: Clinical Decision-Making Between Bispecific Antibodies and CAR T-Cell Therapy. Targets. 2025; 3(4):37.
https://doi.org/10.3390/targets3040037
Chicago/Turabian Style
Canichella, Martina, Raffaella Cerretti, Monika Malgorzata Trawinska, Mariagiovanna Cefalo, Luca Cupelli, Carla Mazzone, Alessandra Checcoli, Alice Di Rocco, Paolo de Fabritiis, and Elisabetta Abruzzese.
2025. "Fatal Early Toxicity After Allogeneic Stem Cell Transplantation in Heavily Pretreated Follicular Lymphoma: Clinical Decision-Making Between Bispecific Antibodies and CAR T-Cell Therapy" Targets 3, no. 4: 37.
https://doi.org/10.3390/targets3040037
APA Style
Canichella, M., Cerretti, R., Trawinska, M. M., Cefalo, M., Cupelli, L., Mazzone, C., Checcoli, A., Di Rocco, A., de Fabritiis, P., & Abruzzese, E.
(2025). Fatal Early Toxicity After Allogeneic Stem Cell Transplantation in Heavily Pretreated Follicular Lymphoma: Clinical Decision-Making Between Bispecific Antibodies and CAR T-Cell Therapy. Targets, 3(4), 37.
https://doi.org/10.3390/targets3040037
